HUE059565T2 - Biológiailag aktív fehérjék expressziója bakteriális sejtmentes szintézisrendszerben, emelkedett exogén chaperonszintû sejtextraktumok segítségével - Google Patents
Biológiailag aktív fehérjék expressziója bakteriális sejtmentes szintézisrendszerben, emelkedett exogén chaperonszintû sejtextraktumok segítségévelInfo
- Publication number
- HUE059565T2 HUE059565T2 HUE14724974A HUE14724974A HUE059565T2 HU E059565 T2 HUE059565 T2 HU E059565T2 HU E14724974 A HUE14724974 A HU E14724974A HU E14724974 A HUE14724974 A HU E14724974A HU E059565 T2 HUE059565 T2 HU E059565T2
- Authority
- HU
- Hungary
- Prior art keywords
- expression
- biologically active
- elevated levels
- synthesis system
- active proteins
- Prior art date
Links
- 102000005431 Molecular Chaperones Human genes 0.000 title 1
- 108010006519 Molecular Chaperones Proteins 0.000 title 1
- 230000001580 bacterial effect Effects 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000000284 extract Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361813914P | 2013-04-19 | 2013-04-19 | |
| US201461937069P | 2014-02-07 | 2014-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE059565T2 true HUE059565T2 (hu) | 2022-11-28 |
Family
ID=50733442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14724974A HUE059565T2 (hu) | 2013-04-19 | 2014-04-18 | Biológiailag aktív fehérjék expressziója bakteriális sejtmentes szintézisrendszerben, emelkedett exogén chaperonszintû sejtextraktumok segítségével |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10190145B2 (enExample) |
| EP (1) | EP2986731B1 (enExample) |
| JP (2) | JP6463732B2 (enExample) |
| KR (1) | KR102289258B1 (enExample) |
| CN (1) | CN105283556B (enExample) |
| AU (1) | AU2014253785B2 (enExample) |
| CA (1) | CA2909516C (enExample) |
| DK (1) | DK2986731T3 (enExample) |
| ES (1) | ES2922358T3 (enExample) |
| HU (1) | HUE059565T2 (enExample) |
| IL (1) | IL242148B (enExample) |
| SG (2) | SG10202108497TA (enExample) |
| WO (1) | WO2014172631A2 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE059565T2 (hu) * | 2013-04-19 | 2022-11-28 | Sutro Biopharma Inc | Biológiailag aktív fehérjék expressziója bakteriális sejtmentes szintézisrendszerben, emelkedett exogén chaperonszintû sejtextraktumok segítségével |
| US10316322B2 (en) * | 2014-07-02 | 2019-06-11 | Sutro Biopharma, Inc. | High growth capacity auxotrophic Escherichia coli and methods of use |
| WO2016073794A1 (en) | 2014-11-05 | 2016-05-12 | Genentech, Inc. | Methods of producing two chain proteins in bacteria |
| WO2016073791A1 (en) | 2014-11-05 | 2016-05-12 | Genentech, Inc. | Methods of producing two chain proteins in bacteria |
| WO2016100889A1 (en) * | 2014-12-19 | 2016-06-23 | Sutro Biopharma, Inc. | Codon optimization for titer and fidelity improvement |
| KR102489471B1 (ko) | 2014-12-30 | 2023-01-18 | 셀진 코포레이션 | 항-cd47 항체 및 그 용도 |
| SI3265557T1 (sl) * | 2015-03-06 | 2020-02-28 | F. Hoffmann-La Roche Ag | Ultraprečiščena DsbA in DsbC ter postopki njune izdelave in uporabe |
| US20170029798A1 (en) * | 2015-07-27 | 2017-02-02 | Cellivery Therapeutics, Inc. | Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD) |
| MX2018002068A (es) * | 2015-08-20 | 2018-06-06 | Genentech Inc | Purificacion de fkpa y usos de la misma para producir polipeptidos recombinantes. |
| CN105198983B (zh) * | 2015-09-11 | 2018-11-06 | 中国石油大学(华东) | 一种利于七次跨膜蛋白ccr5功能性表达的方法 |
| CN106190940B (zh) * | 2016-07-19 | 2019-06-14 | 北京三元基因药业股份有限公司 | 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌 |
| CN106399352B (zh) * | 2016-11-09 | 2020-04-17 | 华东理工大学 | 调节目标蛋白表达的折叠因子及其应用 |
| DK3562940T3 (da) * | 2016-12-30 | 2022-07-11 | Natures Toolbox Inc | Cellefrit ekspressionssystem med hidtil ukendt, uorganisk polyphosphatbaseret energiregeneration |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| KR20240110660A (ko) | 2016-12-30 | 2024-07-15 | 박사이트, 인코포레이티드 | 비자연 아미노산을 갖는 폴리펩타이드-항원 접합체 |
| US12227778B2 (en) | 2016-12-30 | 2025-02-18 | Nature's Toolbox, Inc. | Cell-free expression system having novel inorganic polyphosphate-based energy regeneration |
| AR112756A1 (es) | 2017-07-11 | 2019-12-11 | Synthorx Inc | Incorporación de nucleótidos no naturales, y su método |
| MX2020001336A (es) | 2017-08-03 | 2020-08-20 | Synthorx Inc | Conjugados de citoquina para el tratamiento de enfermedades autoinmunes. |
| US20200181670A1 (en) * | 2017-08-11 | 2020-06-11 | Synvitrobio, Inc. | Improved In Vitro Transcription/Translation (TXTL) System and Use Thereof |
| WO2019127469A1 (zh) * | 2017-12-29 | 2019-07-04 | 康码（上海）生物科技有限公司 | 一种高效的能源再生体系(bes)、试剂盒及其制备方法 |
| TWI834636B (zh) | 2018-02-26 | 2024-03-11 | 美商欣爍克斯公司 | Il-15結合物及其用途 |
| WO2020014543A2 (en) * | 2018-07-11 | 2020-01-16 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| WO2020096959A1 (en) * | 2018-11-05 | 2020-05-14 | Genentech, Inc. | Methods of producing two chain proteins in prokaryotic host cells |
| JP7426389B2 (ja) * | 2018-11-08 | 2024-02-01 | ストロ バイオファーマ， インコーポレイテッド | 酸化的細胞質を有する大腸菌株 |
| JP7636323B2 (ja) | 2018-11-08 | 2025-02-26 | シンソークス， インコーポレイテッド | インターロイキン１０コンジュゲートおよびその使用 |
| CN109371049A (zh) * | 2018-11-14 | 2019-02-22 | 天津大学 | 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用 |
| JP7702872B2 (ja) | 2019-02-06 | 2025-07-04 | シンソークス， インコーポレイテッド | Ｉｌ－２コンジュゲートおよびその使用方法 |
| US12024709B2 (en) | 2019-02-27 | 2024-07-02 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| CA3150163A1 (en) | 2019-08-15 | 2021-02-18 | Synthorx, Inc. | Immuno oncology combination therapies with il-2 conjugates |
| TW202124385A (zh) | 2019-09-10 | 2021-07-01 | 美商欣爍克斯公司 | 治療自體免疫疾病之il-2接合物及使用方法 |
| MX2022005251A (es) | 2019-11-04 | 2022-06-08 | Synthorx Inc | Conjugados de interleuquina 10 y sus usos. |
| EP4056584A4 (en) * | 2019-11-08 | 2024-06-05 | Korea Institute of Ocean Science & Technology | NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF |
| EP4114931A4 (en) * | 2020-03-05 | 2024-05-01 | Curie Co. Inc. | METHODS FOR CELL PROTEIN EXPRESSION OF MATURE POLYPEPTIDES DERIVED FROM ZYMOGENS AND PROPROTEINS |
| CA3175683A1 (en) * | 2020-04-29 | 2021-11-04 | Xueyang FENG | Compositions and methods for enhancing recombinant biosynthesis of cannabinoids |
| BR112022026236A2 (pt) | 2020-06-25 | 2023-01-17 | Synthorx Inc | Terapia de combinação de imuno-oncologia com conjugados de il-2 e anticorpos anti-egfr |
| KR20220000028U (ko) | 2020-06-29 | 2022-01-05 | 채인자 | 농작물용 농약 간편 분무장치 |
| US20220089690A1 (en) * | 2020-09-14 | 2022-03-24 | Sutro Biopharma, Inc. | Method for large scale production of antibodies using a cell-free protein synthesis system |
| IL301612A (en) | 2020-10-09 | 2023-05-01 | Synthorx Inc | Immuno oncology therapies with il-2 conjugates |
| BR112023006364A2 (pt) | 2020-10-09 | 2023-05-09 | Synthorx Inc | Terapia de combinação de imuno-oncologia com conjugados de il-2 e pembrolizumabe |
| WO2022174101A1 (en) | 2021-02-12 | 2022-08-18 | Synthorx, Inc. | Skin cancer combination therapy with il-2 conjugates and cemiplimab |
| EP4291243A1 (en) | 2021-02-12 | 2023-12-20 | Synthorx, Inc. | Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof |
| EP4346903A1 (en) | 2021-06-03 | 2024-04-10 | Synthorx, Inc. | Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab |
| EP4452327A1 (en) | 2021-12-20 | 2024-10-30 | Synthorx, Inc. | Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab |
| WO2023122750A1 (en) | 2021-12-23 | 2023-06-29 | Synthorx, Inc. | Cancer combination therapy with il-2 conjugates and cetuximab |
| CA3255881A1 (en) * | 2022-06-17 | 2023-12-21 | Insitro Inc | In situ sequencing of RNA transcripts with non-uniform 5' ends |
| CN115028691B (zh) * | 2022-06-29 | 2024-09-10 | 青岛硕景生物科技有限公司 | 一种检测试纸用的独立质控系统、杂交瘤细胞株、质控线用包被单克隆抗体及其应用 |
| WO2024136899A1 (en) | 2022-12-21 | 2024-06-27 | Synthorx, Inc. | Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies |
| WO2024196937A1 (en) | 2023-03-20 | 2024-09-26 | Synthorx, Inc. | Cancer therapy with il-2 peg conjugates |
| CN116925196B (zh) * | 2023-06-08 | 2025-04-18 | 齐鲁工业大学(山东省科学院) | 小分子热休克蛋白rsp_1572在提高宿主菌环境耐受性中的应用 |
| WO2025158385A1 (en) | 2024-01-25 | 2025-07-31 | Genzyme Corporation | Pegylated il-2 for suppressing adaptive immune response to gene therapy |
| CN118048325B (zh) * | 2024-04-16 | 2024-07-16 | 天津凯莱英生物科技有限公司 | 酶的高通量筛选方法及酶库的构建方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10145694A1 (de) | 2001-09-17 | 2003-04-03 | Roche Diagnostics Gmbh | Verfahren zur Erhöhung der Löslichkeit, der Expressionsrate und der Aktivität von Proteinen während der rekombinanten Herstellung |
| WO2004081033A2 (en) * | 2003-03-11 | 2004-09-23 | National Institutes Of Health | Synthesis of proteins by cell-free protein expression |
| JP2005253432A (ja) | 2004-03-15 | 2005-09-22 | Sekisui Chem Co Ltd | タンパク質の生産方法、並びにそれに使用するための組成物、試薬及びキット |
| JP4561243B2 (ja) | 2004-08-27 | 2010-10-13 | 株式会社豊田中央研究所 | 無細胞タンパク質合成系のための媒体 |
| AU2007325952B8 (en) * | 2006-06-29 | 2013-06-27 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-free synthesis of proteins containing unnatural amino acids |
| CA2673765A1 (en) * | 2007-01-18 | 2008-07-24 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced cell-free synthesis of active proteins containing disulfide bonds |
| CN102348807B (zh) | 2009-01-12 | 2015-04-15 | 苏特罗生物制药公司 | 利用体外蛋白合成体系将非天然氨基酸引入蛋白的单装载体系 |
| CN102732548A (zh) | 2012-05-16 | 2012-10-17 | 中国农业大学 | 一种表达蛇毒激肽原酶的高效麦胚无细胞蛋白合成系统的建立及应用 |
| JP6421122B2 (ja) * | 2012-10-12 | 2018-11-07 | ストロ バイオファーマ， インコーポレイテッド | 改善された発現のための、細菌抽出物中の選択タンパク質のタンパク質分解不活性化 |
| HUE059565T2 (hu) | 2013-04-19 | 2022-11-28 | Sutro Biopharma Inc | Biológiailag aktív fehérjék expressziója bakteriális sejtmentes szintézisrendszerben, emelkedett exogén chaperonszintû sejtextraktumok segítségével |
-
2014
- 2014-04-18 HU HUE14724974A patent/HUE059565T2/hu unknown
- 2014-04-18 SG SG10202108497TA patent/SG10202108497TA/en unknown
- 2014-04-18 CA CA2909516A patent/CA2909516C/en active Active
- 2014-04-18 DK DK14724974.2T patent/DK2986731T3/da active
- 2014-04-18 KR KR1020157032515A patent/KR102289258B1/ko active Active
- 2014-04-18 JP JP2016509127A patent/JP6463732B2/ja active Active
- 2014-04-18 ES ES14724974T patent/ES2922358T3/es active Active
- 2014-04-18 AU AU2014253785A patent/AU2014253785B2/en active Active
- 2014-04-18 US US14/256,324 patent/US10190145B2/en active Active
- 2014-04-18 CN CN201480032258.8A patent/CN105283556B/zh active Active
- 2014-04-18 WO PCT/US2014/034643 patent/WO2014172631A2/en not_active Ceased
- 2014-04-18 EP EP14724974.2A patent/EP2986731B1/en active Active
- 2014-04-18 SG SG11201508642WA patent/SG11201508642WA/en unknown
-
2015
- 2015-10-18 IL IL242148A patent/IL242148B/en active IP Right Grant
-
2018
- 2018-07-20 JP JP2018136909A patent/JP2018157837A/ja not_active Withdrawn
- 2018-12-03 US US16/208,245 patent/US10774354B2/en active Active
-
2020
- 2020-08-12 US US16/991,607 patent/US20210054429A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6463732B2 (ja) | 2019-02-06 |
| IL242148B (en) | 2019-03-31 |
| HK1220993A1 (en) | 2017-05-19 |
| WO2014172631A4 (en) | 2015-02-19 |
| JP2016518833A (ja) | 2016-06-30 |
| KR20160002913A (ko) | 2016-01-08 |
| US20140315245A1 (en) | 2014-10-23 |
| EP2986731B1 (en) | 2022-05-18 |
| CA2909516A1 (en) | 2014-10-23 |
| SG10202108497TA (en) | 2021-09-29 |
| EP2986731A2 (en) | 2016-02-24 |
| DK2986731T3 (da) | 2022-08-01 |
| US20190161781A1 (en) | 2019-05-30 |
| KR102289258B1 (ko) | 2021-08-11 |
| CA2909516C (en) | 2023-03-07 |
| US10774354B2 (en) | 2020-09-15 |
| US10190145B2 (en) | 2019-01-29 |
| JP2018157837A (ja) | 2018-10-11 |
| WO2014172631A2 (en) | 2014-10-23 |
| CN105283556B (zh) | 2020-07-14 |
| SG11201508642WA (en) | 2015-11-27 |
| WO2014172631A3 (en) | 2014-12-18 |
| US20210054429A1 (en) | 2021-02-25 |
| ES2922358T3 (es) | 2022-09-13 |
| CN105283556A (zh) | 2016-01-27 |
| AU2014253785A1 (en) | 2015-11-05 |
| AU2014253785B2 (en) | 2018-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL242148B (en) | Expression of biologically active proteins in a cell-free bacterial expression system containing high levels of external chaperones | |
| IL273504A (en) | Compositions for cell culture with antioxidants and methods for polypeptide production | |
| IL237530A0 (en) | Gene and protein expression characteristics of adherent stromal cells grown in 3D | |
| SG11201402194RA (en) | Cd40l expressing mammalian cells and their use | |
| HRP20190484T1 (hr) | Pripravci stanične kulture i postupci proizvodnje polipeptida | |
| EP2895594A4 (en) | ELECTROSYNTHETIC MICROBIAL CELLS | |
| GB201100180D0 (en) | Tumour cell and tissue culture | |
| IL240339A0 (en) | An algal cell with impaired chlorophyll with enhanced growth and production | |
| EP2753346A4 (en) | CERAMIDASE AND CELL DIFFERENTIATION | |
| EP3072953A4 (en) | Cell culture container and container in which cell culture has been accommodated | |
| EP3037516A4 (en) | Liquid delivery device and cell culture device using same | |
| SG11201507828VA (en) | Method for culturing hepatoblast-like cells and culture product thereof | |
| IL224813B (en) | Compositions comprising th1 killer cells and uses thereof | |
| CA144250S (en) | Sofa | |
| GB201113641D0 (en) | Cell culture support and cell culture method | |
| PT2861713T (pt) | Método e sistema de cultura celular | |
| EP3068875A4 (en) | Post-natal hematopoeitic endothelial cells and their isolation and use | |
| EP2964746A4 (en) | FERMENTATION MONITORING DEVICE FOR FUEL CELL | |
| PT2753346T (pt) | Ceramidase e diferenciação celular | |
| EP3075846A4 (en) | Cell culture medium and culture method using same | |
| EP2912164A4 (en) | MICRO-RNAS AND CELL PROGRAMMING | |
| PL3008165T3 (pl) | Kontrola konduktywności w fermentacji beztlenowej | |
| EP3042949A4 (en) | Cultivation method for bacteria belonging to genus collimonas and storage method | |
| WO2012166875A9 (en) | Modulating innate immune cell activity by lunasin and selected cytokines | |
| GB201113046D0 (en) | Fermenter and the method of fermentation |